Dissecting the dilemma between in vitro and in vivo drug screening: treating HepG2 cells with Artesunate as a model
K. U. Wong, S. L. Shi, H. Wang, F. Xing, Y. Quan, M. Zhao, L. Zhang, K. H. Wong, A. H. Wong, C. Deng
This study compares in vitro and in vivo drug responses to Artesunate in HepG2 cells, finding discrepancies in efficacy and biomarker expression.
bioRxiv · Aug 27, 2019 · PreprintCell Biology